These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 15120733

  • 1. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S, Sinirtaş M, Ozakin C.
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [Abstract] [Full Text] [Related]

  • 6. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF, Booker BM, Ogundele AB, Kelchin P.
    Diagn Microbiol Infect Dis; 2005 Jul 18; 52(3):255-9. PubMed ID: 15935606
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM, Thorne GM, Luperchio SA, Alder JD.
    Int J Antimicrob Agents; 2006 Nov 18; 28(5):385-8. PubMed ID: 17046205
    [Abstract] [Full Text] [Related]

  • 9. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK.
    Drugs; 2002 Nov 18; 62(3):425-41. PubMed ID: 11827558
    [Abstract] [Full Text] [Related]

  • 10. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K.
    J Antimicrob Chemother; 2004 Apr 18; 53(4):646-9. PubMed ID: 14998986
    [Abstract] [Full Text] [Related]

  • 11. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P, Lemaire S, Denis O, Tulkens PM, Van Bambeke F, Glupczynski Y.
    J Antimicrob Chemother; 2010 Jun 18; 65(6):1228-36. PubMed ID: 20378672
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE, Tenover FC.
    Microb Drug Resist; 2003 Jun 18; 9(4):389-93. PubMed ID: 15000746
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct 18; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 18; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S, Lupo A, Mezzatesta ML, Campanile F, Santagati M, Stefani S.
    Int J Antimicrob Agents; 2008 Mar 18; 31(3):209-15. PubMed ID: 17646087
    [Abstract] [Full Text] [Related]

  • 16. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct 18; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA.
    Ann Acad Med Singap; 2001 May 18; 30(3):320-31. PubMed ID: 11455748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.